OncoCyte Statistics
Share Statistics
OncoCyte has 28.6M
shares outstanding. The number of shares has increased by 113.99%
in one year.
Shares Outstanding | 28.6M |
Shares Change (YoY) | 113.99% |
Shares Change (QoQ) | 69.88% |
Owned by Institutions (%) | 0.34% |
Shares Floating | n/a |
Failed to Deliver (FTD) Shares | 190 |
FTD / Avg. Volume | 0.27% |
Short Selling Information
The latest short interest is 326.72K, so 1.14% of the outstanding
shares have been sold short.
Short Interest | 326.72K |
Short % of Shares Out | 1.14% |
Short % of Float | 2.42% |
Short Ratio (days to cover) | 6.48 |
Valuation Ratios
The PE ratio is -0.51 and the forward
PE ratio is -3.22.
OncoCyte's PEG ratio is
-0.02.
PE Ratio | -0.51 |
Forward PE | -3.22 |
PS Ratio | 16.54 |
Forward PS | 7.4 |
PB Ratio | -2.53 |
P/FCF Ratio | -1.47 |
PEG Ratio | -0.02 |
Financial Ratio History Enterprise Valuation
Currently the Enterprise Value (EV) is not available for OncoCyte.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.62,
with a Debt / Equity ratio of -0.3.
Current Ratio | 1.62 |
Quick Ratio | 1.56 |
Debt / Equity | -0.3 |
Debt / EBITDA | -0.06 |
Debt / FCF | -0.17 |
Interest Coverage | -726.68 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $40,891.3 |
Profits Per Employee | $-1,318,760.87 |
Employee Count | 46 |
Asset Turnover | 0.05 |
Inventory Turnover | 2.78 |
Taxes
Income Tax | n/a |
Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 21.2% in the
last 52 weeks. The beta is 0.96, so OncoCyte's
price volatility has been higher than the market average.
Beta | 0.96 |
52-Week Price Change | 21.2% |
50-Day Moving Average | 3.06 |
200-Day Moving Average | 2.82 |
Relative Strength Index (RSI) | 66.89 |
Average Volume (20 Days) | 69,100 |
Income Statement
In the last 12 months, OncoCyte had revenue of 1.88M
and earned -60.66M
in profits. Earnings per share was -4.66.
Revenue | 1.88M |
Gross Profit | 740K |
Operating Income | -61.04M |
Net Income | -60.66M |
EBITDA | -59.02M |
EBIT | -60.58M |
Earnings Per Share (EPS) | -4.66 |
Full Income Statement Balance Sheet
The company has 8.64M in cash and 3.66M in
debt, giving a net cash position of 4.97M.
Cash & Cash Equivalents | 8.64M |
Total Debt | 3.66M |
Net Cash | 4.97M |
Retained Earnings | -350.54M |
Total Assets | 60.36M |
Working Capital | 26.58M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -20.71M
and capital expenditures -516K, giving a free cash flow of -21.23M.
Operating Cash Flow | -20.71M |
Capital Expenditures | -516K |
Free Cash Flow | -21.23M |
FCF Per Share | -1.62 |
Full Cash Flow Statement Margins
Gross margin is 39.34%, with operating and profit margins of -3245.14% and -3225.04%.
Gross Margin | 39.34% |
Operating Margin | -3245.14% |
Pretax Margin | -3225.04% |
Profit Margin | -3225.04% |
EBITDA Margin | -3137.43% |
EBIT Margin | -3245.14% |
FCF Margin | -1128.6% |